OMT Grants Unlimited OmniRat, OmniMouse and OmniFlic License
October 01, 2014 at 11:22 AM EDT
PALO ALTO, Calif.---- Open Monoclonal Technology, Inc., an innovator of novel genetic engineering of animals for creation of human therapeutic antibodies, today announced an alliance with Genmab A/S, a biotechnology company specializing in human antibody therapeutics.
